Swissport The Netherlands awarded with IATA CEIV Pharma Certification
With the increasing flow of Life Science & Healthcare shipments over the past few years, maintaining a stable and secure supply chain requires specific equipment, storage facilities, harmonized handling procedures and above all, strong cooperation among the cool chain partners. Swissport The Netherlands started to develop a dedicated product line for the handling of Life Science & Healthcare shipments. With the recent acquisition of Terminal 9, the scope for this product line was broadened and today, all of Swissport’s operational activities in the Netherlands (both Terminal 9 and 11) are successfully awarded by the IATA CEIV certification.
“The certificate is a validation of the hard work that our team put in the pharma product”, said Jeroen Giling, Director Cargo at Swissport The Netherlands. “But that is not where we stop. In cooperation with our valued customers, we believe that the pharma product is a product line with continuous improvement cycles. This means that we will keep investing in training our staff, maintaining the best controlled pharma facilities and further develop procedures to ensure a secure and high quality pharma chain.”
Swissport International Ltd. provides ground services for more than 230 million passengers and handles 4.3 million tonnes of cargo a year on behalf of some 835 client-companies in the aviation sector. With a workforce of more than 62,000 personnel, Swissport is active at more than 280 stations in 48 countries across five continents, and generates consolidated operating revenue of EUR 2.7 billion. www.swissport.com
For more information please contact:
Swissport International Ltd.
+41 43 815 00 00